Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.58)
# 3,724
Out of 4,791 analysts
73
Total ratings
17.19%
Success rate
-24.62%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Maintains: Buy | $20 → $15 | $6.72 | +123.21% | 5 | Mar 18, 2025 | |
| ILMN Illumina | Maintains: Hold | $135 → $115 | $81.88 | +40.45% | 8 | Mar 11, 2025 | |
| NTRA Natera | Maintains: Buy | $180 → $195 | $143.20 | +36.17% | 8 | Feb 28, 2025 | |
| GH Guardant Health | Maintains: Buy | $42 → $60 | $43.49 | +37.96% | 5 | Feb 24, 2025 | |
| RGEN Repligen | Maintains: Hold | $165 → $170 | $130.92 | +29.85% | 2 | Feb 21, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $18 | $8.85 | +103.39% | 7 | Feb 13, 2025 | |
| XGN Exagen | Maintains: Buy | $5 → $7 | $4.43 | +58.01% | 2 | Jan 3, 2025 | |
| AKYA Akoya Biosciences | Maintains: Buy | $6 → $3.5 | $1.36 | +157.35% | 3 | Nov 15, 2024 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $3 | $1.47 | +104.08% | 4 | Nov 14, 2024 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $1.23 | -18.70% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $44.56 | +68.31% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $42 | $20.19 | +108.02% | 3 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.27 | +136.22% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $0.63 | +457.59% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.56 | +257.14% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.68 | +7,183.49% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $1.95 | +874.36% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.11 | +141,409.43% | 1 | Jan 29, 2021 |
Quanterix
Mar 18, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $6.72
Upside: +123.21%
Illumina
Mar 11, 2025
Maintains: Hold
Price Target: $135 → $115
Current: $81.88
Upside: +40.45%
Natera
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $143.20
Upside: +36.17%
Guardant Health
Feb 24, 2025
Maintains: Buy
Price Target: $42 → $60
Current: $43.49
Upside: +37.96%
Repligen
Feb 21, 2025
Maintains: Hold
Price Target: $165 → $170
Current: $130.92
Upside: +29.85%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.85
Upside: +103.39%
Exagen
Jan 3, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $4.43
Upside: +58.01%
Akoya Biosciences
Nov 15, 2024
Maintains: Buy
Price Target: $6 → $3.5
Current: $1.36
Upside: +157.35%
Lucid Diagnostics
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.47
Upside: +104.08%
Quantum-Si incorporated
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.23
Upside: -18.70%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $44.56
Upside: +68.31%
Oct 29, 2024
Maintains: Buy
Price Target: $35 → $42
Current: $20.19
Upside: +108.02%
Aug 8, 2024
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.27
Upside: +136.22%
Mar 4, 2024
Reiterates: Buy
Price Target: $3.5
Current: $0.63
Upside: +457.59%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.56
Upside: +257.14%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.68
Upside: +7,183.49%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $1.95
Upside: +874.36%
Jan 29, 2021
Initiates: Overweight
Price Target: $150
Current: $0.11
Upside: +141,409.43%